SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales moved up 27.37% to Rs. 14981.60 millions for the September 2022 quarter as compared to Rs. 11762.00 millions during the year-ago period.A slim rise of 15.08% was recorded in the Net profit for the quarter ended September 2022 to Rs. 2274.40  millions  From Rs. 1976.30 millions.Operating Profit saw a handsome growth to 4301.40 millions from 3383.10 millions in the quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 14981.60 11762.00 27.37 29934.10 23968.00 24.89 47070.40 47687.20 -1.29
Other Income 41.00 45.00 -8.89 70.30 120.70 -41.76 215.50 273.20 -21.12
PBIDT 4301.40 3383.10 27.14 8512.50 7089.40 20.07 13067.50 15371.90 -14.99
Interest 379.10 205.90 84.12 654.10 456.30 43.35 958.60 659.20 45.42
PBDT 3922.30 3177.20 23.45 7858.40 6633.10 18.47 12108.90 14712.70 -17.70
Depreciation 755.50 593.30 27.34 1415.50 1148.20 23.28 2354.80 1966.40 19.75
PBT 3166.80 2583.90 22.56 6442.90 5484.90 17.47 9754.10 12746.30 -23.48
TAX 892.40 607.60 46.87 1852.40 1287.80 43.84 2253.20 3185.20 -29.26
Deferred Tax 0.80 -59.60 -101.34 -69.00 114.70 -160.16 -61.00 -164.60 -62.94
PAT 2274.40 1976.30 15.08 4590.50 4197.10 9.37 7500.90 9561.10 -21.55
Equity 1074.70 1073.20 0.14 1074.70 1073.20 0.14 1074.70 1073.20 0.14
PBIDTM(%) 28.71 28.76 -0.18 28.44 29.58 -3.86 27.76 32.23 -13.88

Laurus Labs Share Price

1164.00 -2.50 (-0.21%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1820.75
Dr. Reddys Lab 1270.95
Cipla 1333.55
Zydus Lifesciences 911.85
Lupin 2343.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×